TenX.
A human centered design and technology studio.
- Reports this week
- 0
- Active events
- 0
- Connections
- 13
What's happening
Earlier this month
Gone quiet
No new reports in 90+ days-
TenX experienced a clinical trial failure on August 12, 2026, causing a drop in its stock value.Some support1 report
-
TenX plans to consult both the FDA and EMA regarding the results of its clinical trials.Some support1 report
-
William Blair reissued an outperform rating for TenX, while Cantor Fitzgerald reaffirmed an overweight rating on July 3, 2026.Some support3 reports
No events began in the chosen period. Widen it, or reset.
Around TenX this week
News at the entities that move TenX most-
Nasdaq StructuralDario Amodei rang the Nasdaq bell on November 20, 2026.Moves TenX
-
SEC StructuralStock trades occurred on the NYSE platform while filing disclosures with the SEC.Moves TenX
-
FDA StructuralDEA guidance restricts state-licensed supply chains in Pennsylvania, relating to FDA-approved products.Moves TenX
-
Cantor Fitzgerald Mentioned togetherCantor Fitzgerald, led by Gerard Casey, has established an operational presence in Ireland, with offices in Dublin, Limerick, and Cork.Moves TenX
-
MarketBeat Mentioned togetherMarketBeat used its stock screener tool to highlight Walmart.Moves TenX
Connections
The 8 strongest of 13, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Nasdaq Structural
TenX is a company whose securities are listed and traded on the Nasdaq stock exchange.
-
SEC Structural
TenX is subject to SEC regulatory requirements, mandating the filing of specific transactions.
-
FDA Structural
TenX engages with the FDA for regulatory reviews and consultations regarding its drug development plans and trial results.
-
MarketBeat Mentioned together
MarketBeat functions as a major information aggregator and publisher of news and analyst ratings for TenX.
-
Cantor Fitzgerald Mentioned together
Cantor Fitzgerald provided an overweight rating on TenX.
-
William P. Blair Mentioned together
William Blair issued an outperform rating on TenX.
-
EMA Structural
The company plans to consult EMA regarding the outcomes of its clinical trials.
-
Stuart Rich Mentioned together
No direct relationship between TenX and Stuart Rich was observed in the provided evidence.